These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L; J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717 [TBL] [Abstract][Full Text] [Related]
5. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. Oktem IM; Gulay Z; Bicmen M; Gur D; Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128 [TBL] [Abstract][Full Text] [Related]
6. Detection of extended spectrum beta-lactamases-producing isolates and effect of AmpC overlapping. Hassan MI; Alkharsah KR; Alzahrani AJ; Obeid OE; Khamis AH; Diab A J Infect Dev Ctries; 2013 Aug; 7(8):618-29. PubMed ID: 23949298 [TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of extended spectrum β-lactamase-producing Enterobacteriaceae strains isolated from a tertiary care hospital. Jena J; Debata NK; Sahoo RK; Gaur M; Subudhi E Microb Pathog; 2018 Feb; 115():112-116. PubMed ID: 29274456 [TBL] [Abstract][Full Text] [Related]
8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system. Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160 [TBL] [Abstract][Full Text] [Related]
9. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe. Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y; Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection. Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168 [TBL] [Abstract][Full Text] [Related]
11. Prevalence, molecular characterization, and phenotypic confirmation of extended-spectrum beta-lactamases in Escherichia coli, Klebsiella pneumoniae, and Klebsiella oxytoca at the Radboud University Nijmegen Medical Centre in The Netherlands. Sturm PD; Bochum ET; van Mook-Vermulst SV; Handgraaf C; Klaassen T; Melchers WJ Microb Drug Resist; 2010 Mar; 16(1):55-60. PubMed ID: 20001741 [TBL] [Abstract][Full Text] [Related]
12. Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and CLSI screening parameters for the detection of extended-spectrum β-lactamase production in clinical Enterobacteriaceae isolates. Polsfuss S; Bloemberg GV; Giger J; Meyer V; Hombach M J Antimicrob Chemother; 2012 Jan; 67(1):159-66. PubMed ID: 21972269 [TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216 [TBL] [Abstract][Full Text] [Related]
14. Use of boronic acid disk tests to detect extended- spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing enterobacteriaceae. Tsakris A; Poulou A; Themeli-Digalaki K; Voulgari E; Pittaras T; Sofianou D; Pournaras S; Petropoulou D J Clin Microbiol; 2009 Nov; 47(11):3420-6. PubMed ID: 19726597 [TBL] [Abstract][Full Text] [Related]
15. Plasmid-Mediated AmpC β-Lactamase and Underestimation of Extended-Spectrum β-Lactamase in Cefepime-Susceptible Elevated-Ceftazidime-MIC Enterobacteriaceae Isolates. Nishimura F; Morinaga Y; Akamatsu N; Matsuda J; Kaku N; Takeda K; Uno N; Kosai K; Hasegawa H; Yanagihara K Jpn J Infect Dis; 2018 Jul; 71(4):281-285. PubMed ID: 29709981 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of plasmid-mediated quinolone resistance determinants in ESBL Enterobacteriaceae clinical isolates over a 1-year period in a French hospital. Crémet L; Caroff N; Dauvergne S; Reynaud A; Lepelletier D; Corvec S Pathol Biol (Paris); 2011 Jun; 59(3):151-6. PubMed ID: 19481883 [TBL] [Abstract][Full Text] [Related]
17. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007. Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410 [TBL] [Abstract][Full Text] [Related]
18. β-lactamases produced by amoxicillin-clavulanate-resistant enterobacteria isolated in Buenos Aires, Argentina: a new blaTEM gene. Di Conza JA; Badaracco A; Ayala J; Rodríguez C; Famiglietti A; Gutkind GO Rev Argent Microbiol; 2014; 46(3):210-7. PubMed ID: 25444130 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic detection of AmpC β-lactamases, extended-spectrum β-lactamases and metallo-β-lactamases in Enterobacteriaceae using a resazurin microtitre assay with inhibitor-based methods. Teethaisong Y; Eumkeb G; Chumnarnsilpa S; Autarkool N; Hobson J; Nakouti I; Hobbs G; Evans K J Med Microbiol; 2016 Oct; 65(10):1079-1087. PubMed ID: 27481506 [TBL] [Abstract][Full Text] [Related]
20. Phenotypic expression and prevalence of ESBL-producing Enterobacteriaceae in samples collected from patients in various wards of Mulago Hospital, Uganda. Kateregga JN; Kantume R; Atuhaire C; Lubowa MN; Ndukui JG BMC Pharmacol Toxicol; 2015 Jun; 16():14. PubMed ID: 26031914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]